跳到正文
原文
Nature 健康护理主题·· 2026-10-20AI 评分12

Eye 更正:Aflibercept 8 mg 用于新生血管性年龄相关性黄斑变性和糖尿病性黄斑水肿——将临床试验转化为临床实践

Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice

AI 导读

《Eye》发布更正,涉及 Aflibercept 8 mg 用于新生血管性年龄相关性黄斑变性和糖尿病性黄斑水肿、将临床试验转化为临床实践的论文。更正了正文、参考文献、资助及利益冲突部分中的笔误,原文已更正。

正文

Correction to: Eye https://doi.org/10.1038/s41433-026-04779-5, published online 07 August 2026

In this article typos in text, references, funding and competing interest section have been corrected.

The original article has been corrected.

Author information

Authors and Affiliations

  1. NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK

    Sobha Sivaprasad

  2. Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USA

    Michael W. Stewart

  3. Retina Consultants of Texas, Retina Consultants of America, Houston, TX, USA

    Charles C. Wykoff

  4. Retina Vitreous Associates of Florida, Saint Petersburg, FL, USA

    David Eichenbaum

  5. Morsani College of Medicine at the University of South Florida, Tampa, FL, USA

    David Eichenbaum

  6. CHU Bordeaux, Service d’Ophtalmologie, Bordeaux, France

    Jean-Francois Korobelnik

  7. University of Bordeaux, INSERM, BPH, UMR1219, Bordeaux, France

    Jean-Francois Korobelnik

  8. Department of Medicine-Ophthalmology, University of Udine, Udine, Italy

    Paolo Lanzetta

  9. Istituto Europeo di Microchirurgia Oculare-IEMO, Udine, Italy

    Paolo Lanzetta

  10. Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada

    Varun Chaudhary

  11. Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, ON, Canada

    Varun Chaudhary

  12. Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore

    Chui Ming Gemmy Cheung & Tien Yin Wong

  13. Duke-National University of Singapore Medical School, Singapore, Singapore

    Chui Ming Gemmy Cheung & Tien Yin Wong

  14. Hull York Medical School, University of York, York, UK

    Richard Gale

  15. Hull York Medical School, University of York, and York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK

    Richard Gale

  16. Gutblick Practise Group, Pfäffikon, Switzerland

    Marion R. Munk

  17. Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

    Marion R. Munk

  18. Department of Ophthalmology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

    Marion R. Munk

  19. Department of Ophthalmology, Kagoshima University, Kagoshima, Japan

    Taiji Sakamoto

  20. Department of Ophthalmology, University Medicine Greifswald, Mecklenburg-Vorpommern, Greifswald, Germany

    Andreas Stahl

  21. Hospital Clínic de Barcelona, Barcelona, Spain

    Javier Zarranz-Ventura

  22. Department of Surgery and Medical-Surgical Specialties, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain

    Javier Zarranz-Ventura

  23. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

    Javier Zarranz-Ventura

  24. Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Beijing, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China

    Tien Yin Wong

  25. School of Biomedical Engineering, Tsinghua Medicine, Tsinghua University, Beijing, China

    Tien Yin Wong

  26. Department of Ophthalmology and GRADE Reading Center, University of Bonn, Bonn, Germany

    Frank G. Holz

  27. Department of Ophthalmology, Tel Aviv Medical Centre, Tel Aviv, Israel

    Anat Loewenstein

  28. Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel

    Anat Loewenstein

Authors

  1. Sobha Sivaprasad
  2. Michael W. Stewart
  3. Charles C. Wykoff
  4. David Eichenbaum
  5. Jean-Francois Korobelnik
  6. Paolo Lanzetta
  7. Varun Chaudhary
  8. Chui Ming Gemmy Cheung
  9. Richard Gale
  10. Marion R. Munk
  11. Taiji Sakamoto
  12. Andreas Stahl
  13. Javier Zarranz-Ventura
  14. Tien Yin Wong
  15. Frank G. Holz
  16. Anat Loewenstein

Corresponding author

Correspondence to Anat Loewenstein.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sivaprasad, S., Stewart, M.W., Wykoff, C.C. et al. Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice. Eye (2026). https://doi.org/10.1038/s41433-026-04887-2

Download citation

  • Published: 20 October 2026

  • Version of record: 20 October 2026

  • DOI: https://doi.org/10.1038/s41433-026-04887-2

来源:Nature 健康护理主题 · nature.com